首页> 外文期刊>Clinical proteomics. >Clinical proteomics of enervated neurons
【24h】

Clinical proteomics of enervated neurons

机译:活化神经元的临床蛋白质组学

获取原文
获取原文并翻译 | 示例
           

摘要

The dynamic field of neurosciences entails ever increasing search for molecular mechanisms of disease states, especially in the domain of neurodegenerative disorders. The previous century heralded the techniques in proteomics when indexing of the human proteomes relating to various disease conditions became important. Early stage research in certain diseases or pathological conditions requires a more holistic approach of first discovering the proteins of interest for the condition. Despite its limitations, proteomics is one of the most powerful techniques available to us today to dissect the molecular scenario in a particular disease situation. In this review we will discuss about the current clinical research in neurodegenerative disorders that employ proteomics techniques. We will specifically focus on our understanding of Alzheimer's disease, traumatic spinal cord injury and neuromyelitis optica. Discussions will include ongoing worldwide research in these areas, research in India and specifically our laboratory in these domains of neurodegenerative conditions. The most polarized cells of the human body, neurons, are a specialized type with respect to their functional properties. Development and function of neurons are closely linked to the bidirectional transport of molecules from the synaptic end to the cell body. This very synaptic signal, which when disrupted, causes the dysfunction of neuronal activities. Disruption in axonal transport is the cause of several neurodegenerative disorders [1, 2]. In the realm of peripheral neuron injury, retrograde transport of molecules from the site of injury to the cell body of a peripheral neuron primes the latter to regenerate [3, 4]. This phenomenon is absent in the central nervous system (CNS), with the consequence of regeneration after CNS injury being elusive even with years of research. Partly because of the large distance separating the axon end from the cell body, many molecular events after a trauma or a neuronal disease occur without any transcriptional manifestations [5]. Local proteolysis, protein synthesis and post translational modifications are the key to understanding axonal events after an assault or a disorder of the neuron [5]. Proteomics approaches have therefore come to the limelight in recent times. In this review, we will discuss the contributions of our group from this perspective and also the prospective ideas in three neurological degenerative situations, namely Alzheimer's disease (AD), traumatic spinal cord injury (SCI) and neuromyelitis optica (NMO) and explore the advances in understanding these pathological processes using proteomics approaches.
机译:神经科学的动态领域要求对疾病状态的分子机制的研究不断增加,尤其是在神经退行性疾病领域。当与各种疾病状况相关的人类蛋白质组索引变得重要时,上个世纪预示了蛋白质组学技术的发展。在某些疾病或病理状况下的早期研究需要一种更全面的方法,首先发现该状况下感兴趣的蛋白质。尽管有其局限性,蛋白质组学仍然是当今我们用来剖析特定疾病情况下分子情况的最强大技术之一。在这篇综述中,我们将讨论有关采用蛋白质组学技术的神经退行性疾病的最新临床研究。我们将特别专注于对阿尔茨海默氏病,脊髓损伤和视神经脊髓炎的理解。讨论将包括在这些领域正在进行的全球研究,在印度的研究,特别是我们在神经退行性疾病领域的实验室研究。人体中最极化的细胞,神经元,就其功能特性而言是一种特殊的类型。神经元的发育和功能与分子从突触末端到细胞体的双向运输密切相关。这种非常突触的信号,当被破坏时,会引起神经元活动的功能障碍。轴突运输的中断是几种神经退行性疾病的原因[1、2]。在周围神经元损伤的领域,分子从损伤部位向周围神经元细胞体的逆行转运使后者再生[3,4]。这种现象在中枢神经系统(CNS)中不存在,即使经过多年的研究,CNS损伤后的再生仍然难以捉摸。部分是由于轴突末端与细胞体之间的距离较大,在发生外伤或神经元疾病后发生了许多分子事件,而没有任何转录表现[5]。局部蛋白水解,蛋白质合成和翻译后修饰是理解神经元受到攻击或紊乱后轴突事件的关键[5]。因此,蛋白质组学方法近来备受关注。在这篇综述中,我们将从这个角度讨论我们小组的贡献,以及在三种神经退行性疾病,即阿尔茨海默氏病(AD),脊髓损伤性脊髓损伤(SCI)和视神经脊髓炎(NMO)方面的前瞻性想法,并探讨其进展使用蛋白质组学方法了解这些病理过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号